Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/xeris-biopharma-scores-fda-approval-for-endogenous-cushing-s-syndrome-drug-recorlev
https://www.globenewswire.com/news-release/2021/10/05/2309125/37274/en/Strongbridge-Biopharma-plc-Announces-Completion-of-Acquisition-by-Xeris-Pharmaceuticals-Inc.html
https://www.globenewswire.com/news-release/2021/09/23/2302588/37274/en/Strongbridge-Biopharma-plc-Announces-Court-Hearing-Date-to-Approve-Proposed-Acquisition-by-Xeris-Pharmaceuticals-Inc.html
https://www.globenewswire.com/news-release/2021/09/08/2293797/37274/en/Strongbridge-Biopharma-plc-Announces-Shareholder-Approval-of-Proposed-Acquisition-by-Xeris-Pharmaceuticals-Inc.html
https://www.globenewswire.com/news-release/2021/08/05/2275480/37274/en/Strongbridge-Biopharma-plc-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2021/08/02/2272724/37274/en/Strongbridge-Biopharma-plc-Announces-Commencement-of-Mailing-of-Proxy-Statement.html
https://www.globenewswire.com/news-release/2021/07/29/2271272/37274/en/Strongbridge-Biopharma-plc-Provides-Announcement-Under-the-Irish-Takeover-Rules-for-Relevant-Securities-in-Issue.html
https://www.globenewswire.com/news-release/2021/07/29/2271179/37274/en/Strongbridge-Biopharma-plc-to-Report-Second-Quarter-2021-Financial-Results-on-August-5-2021.html